Physician

Ahmad Anjak, MD

According to 2025 Medicare claims, Ahmad Anjak, MD (NPI: 1033158688) practices nephrology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Butler, OH. This provider's primary affiliated billing organization is UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY, LLC (NPI: 1801840434; TIN: 311405915) and primary practice location at 41075-9998. Anjak is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Anjak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 519 traditional Medicare patients, billed 1,603 HCPCS/CPT codes, and received $120,630 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 2,939 prescription claims across 374 beneficiaries totaling $420,933 in drug costs, led by Jardiance (Empagliflozin). DME data shows 320 claims. Open Payments data shows 10 records totaling $2,230. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $27,078 to $420,933. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,042 and ending at $967.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	944	3,869	$253,538
2016	634	2,541	$156,372
2017	215	404	$24,426
2018	301	630	$48,137
2019	766	1,827	$135,581
2020	652	1,687	$127,323
2021	696	1,826	$152,901
2022	775	1,911	$149,122
2023	623	1,815	$144,220
2024	519	1,603	$120,630

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	160	730	$27,078
2016	163	477	$18,786
2017	67	413	$28,246
2018	62	341	$47,899
2019	136	630	$27,737
2020	115	575	$47,565
2021	215	1,636	$81,889
2022	239	2,925	$169,767
2023	316	2,878	$251,280
2024	374	2,939	$420,933

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	28	$1,298
2016	N/R	15	$94
2017	N/R	37	$1,568
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	22	$967
2021	N/R	N/R	N/R
2022	N/R	31	$474
2023	N/R	157	$1,700
2024	N/R	320	$16,140

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	57	164	$90
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	54	145	$69
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	213	326	$68
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	52	131	$48
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	141	174	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	208	9,995	$196,861
Lokelma	Sodium Zirconium Cyclosilicate	46	1,324	$36,945
Eliquis	Apixaban	51	1,493	$27,894
Tradjenta	Linagliptin	22	635	$11,919
Sevelamer Carbonate	Sevelamer Carbonate	31	1,281	$6,494

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	23	$12,979
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	100	$1,254
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	60	$1,092
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	59	$439
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	30	$345

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$2,230	CALLIDITAS THERAPEUTICS US INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Anjak, MD?

Tedicare shows public-source Medicare data for Ahmad Anjak, MD (NPI 1033158688), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Anjak, MD have ACO affiliation data?

Ahmad Anjak, MD is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Ahmad Anjak, MD?

Ahmad Anjak, MD is linked to UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY, LLC (billing NPI 1801840434) in the available physician profile data.

Does Ahmad Anjak, MD have Open Payments data?

Ahmad Anjak, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.